Enhanced Diagnostics in Orthopedic Infections: Overcoming the Limitations of Culture with Molecular Testing
Accurate diagnosis of orthopedic infections is crucial for successful patient treatment. Bone and joint infections (BJI) are particularly challenging, with up to 50% of cases reported as 'culture negative'.
Marina Linow, product manager, Molzym GmbH & Co. KG, will explore studies comparing traditional culture-based methods with advanced molecular techniques to enhance diagnostic accuracy. She will examine the limitations of conventional cultures, as well as the factors influencing molecular testing and their impact on the accuracy and efficiency of culture-independent molecular diagnostics.
Key learning objectives
- Understand the constraints of traditional culture methods
- Identify the variables that affect the accuracy and efficiency of culture-independent molecular tests
- Understand the diagnostic impact of human DNA depletion for culture-independent infection diagnosis
Who should attend?
- Lab directors, lab managers, quality managers
- Medical laboratory scientists and technicians
- Molecular microbiologists
- Clinical lab scientists
- Clinicians, infectious disease Specialists, pathologist, and medical doctor
- Researchers, microbiologists, and biotechnologists
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes
Speakers
Marina Linow is the product manager for the research and diagnostic product lines at Molzym GmbH & Co. KG. In her role, she works closely with key opinion leaders in the molecular diagnostics and NGS community to identify and understand the needs in this field. She leads collaborative projects and provides in-depth scientific support to customers and partners.
Moderator
